Press Releases

About Avicanna

Strategically positioned to be a front runner in the;
• Development
• Manufacturing and;
• Commercialization of plant-derived cannabinoid-based products

June 24, 2021

Avicanna Announces Results of Annual General Meeting and Provides Corporate Update

TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) is pleased to announce that all of management’s nominees listed in the Company’s management information circular dated May 25, 2021 were elected as directors of the Company at Avicanna’s annual general meeting of shareholders held on June 24, 2021 (the “Meeting”). The detailed results of the vote for the election of directors held at the Meeting are set out below.

June 15, 2021

Avicanna Expands The Canadian RHO Phyto Product Offerings With The Addition Of THC-Free High CBD Oral And Sublingual Formulation Across Medical And Adult Use Channels

TORONTO, June 15, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and …

June 3, 2021

Avicanna Announces Mailing of Management Information Circular and Proposed Board Changes

TORONTO, June 3, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) is announcing that it has commenced mailing its management information circular (the “Information Circular”) and related proxy materials in relation to Avicanna’s annual general meeting of …

May 26, 2021

Avicanna’s Evidence-Based and Dermatologist Tested CBD Derma-Cosmetic Brand Pura Earth™ to be Launched in Adult-Use and Medical Channels Across Canada in Q2 2021.

TORONTO, May 26, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” …

Avicanna Makes RHO Phyto™ Medical Cannabis Products Available In Canadian Hospital Pharmacies Through Agreement with Sunnybrook Hospital – May 6, 2021
Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order – April 26, 2021
Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update – April 12, 2021
Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order – March 29, 2021
Avicanna Closes Non-Brokered Private Placement Raising $5.6 Million – Mar 4, 2021
Avicanna Announces Exercise And Closing Of Over-Allotment Option – Dec 31, 2020
Avicanna Announces Closing of Public Offering of Units – Dec 8, 2020
Avicanna Announces Overnight Marketed Public Offering of Units – Nov 12, 2020
Avicanna Reports Third Quarter 2020 Financial Results and Provides Corporate Update – Nov 12, 2020
Avicanna Closes Non-Brokered Private Placement Raising $2.7 Million – Aug 18, 2020
Avicanna Reports Second Quarter 2020 Financial Results and Provides Corporate Update – Aug 17, 2020
Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update – May 25, 2020
Avicanna Closes Non-Brokered Private – Placement with Group of Strategic Investors and Announces Warrant Re-Pricing – April 21, 2020
Avicanna Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update – April 15, 2020
Avicanna Closes First Tranche of Private Placement – January 24, 2020
Avicanna Reports Third Quarter 2019 Financial Results – Nov. 14, 2019
Avicanna Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes – Aug 23, 2019
Avicanna Reports Second Quarter 2019 Financial Results – Aug 14, 2019
Avicanna Commences Trading on the TSX Under the Symbol “AVCN” – July 18, 2019
Avicanna Announces TSX Listing Date – July 16, 2019
Avicanna Announces Receipt for Final Prospectus and Conditional Approval for Listing on the TSX – July 10, 2019
Avicanna Closes Oversubscribed $22.1 Million Special Warrant Offering – April 18, 2019
Avicanna Announces Filing of Preliminary Prospectus – January 21, 2019
Avicanna Inc. Acquires 60% Stake in Colombian Medical Marijuana Firm Santa Marta Golden Hemp – August 16, 2018
Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder – January 29, 2018
Avicanna Closes its First Equity Financing and Announces its Residency at Johnson & Johnson Innovation, JLABS @ Toronto – May 26, 2017


480 University Ave, Suite 1502
Toronto, ON M5G 1V2

Want to stay up to date? Subscribe to receive email updates.

© 2017-2019 Avicanna Inc. All Rights Reserved.

Sign up and join our Newsletter  

Stay updated with all latest
updates and news.